- Home
- BLDP vs EBS Comparison
BLDP vs EBS Comparison
Compare BLDP & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDP
- EBS
- Stock Information
- Founded
- BLDP 1979
- EBS 1998
- Country
- BLDP Canada
- EBS United States
- Employees
- BLDP N/A
- EBS N/A
- Industry
- BLDP Industrial Machinery/Components
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- BLDP Energy
- EBS Health Care
- Exchange
- BLDP Nasdaq
- EBS Nasdaq
- Market Cap
- BLDP 383.2M
- EBS 459.6M
- IPO Year
- BLDP 1995
- EBS 2006
- Fundamental
- Price
- BLDP $1.28
- EBS $9.40
- Analyst Decision
- BLDP Hold
- EBS Strong Buy
- Analyst Count
- BLDP 11
- EBS 2
- Target Price
- BLDP $2.27
- EBS $14.00
- AVG Volume (30 Days)
- BLDP 4.3M
- EBS 1.6M
- Earning Date
- BLDP 11-05-2024
- EBS 11-06-2024
- Dividend Yield
- BLDP N/A
- EBS N/A
- EPS Growth
- BLDP N/A
- EBS N/A
- EPS
- BLDP N/A
- EBS N/A
- Revenue
- BLDP $91,962,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- BLDP N/A
- EBS $7.98
- Revenue Next Year
- BLDP $25.65
- EBS $6.62
- P/E Ratio
- BLDP N/A
- EBS N/A
- Revenue Growth
- BLDP 24.01
- EBS 2.05
- 52 Week Low
- BLDP $1.23
- EBS $1.42
- 52 Week High
- BLDP $4.01
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- BLDP 35.48
- EBS 50.73
- Support Level
- BLDP $1.23
- EBS $8.12
- Resistance Level
- BLDP $1.42
- EBS $12.68
- Average True Range (ATR)
- BLDP 0.10
- EBS 0.91
- MACD
- BLDP -0.01
- EBS -0.18
- Stochastic Oscillator
- BLDP 8.77
- EBS 33.67
About BLDP Ballard Power Systems Inc.
Ballard Power Systems Inc is a world leader in proton-exchange membrane fuel cells, power system development, and commercialization. The company's principal business is the design, development, manufacture, sale, and service of PEM fuel cell products for a variety of applications, focusing on power product markets of heavy-duty motive (bus, truck, rail, and marine applications), material handling, and stationary power generation. Sales are concentrated in the US, Europe, and China.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.